Tomomitsu Miyagaki

5.4k total citations · 1 hit paper
131 papers, 2.8k citations indexed

About

Tomomitsu Miyagaki is a scholar working on Dermatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Tomomitsu Miyagaki has authored 131 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Dermatology, 55 papers in Immunology and 42 papers in Pathology and Forensic Medicine. Recurrent topics in Tomomitsu Miyagaki's work include Cutaneous lymphoproliferative disorders research (64 papers), Lymphoma Diagnosis and Treatment (23 papers) and Dermatology and Skin Diseases (21 papers). Tomomitsu Miyagaki is often cited by papers focused on Cutaneous lymphoproliferative disorders research (64 papers), Lymphoma Diagnosis and Treatment (23 papers) and Dermatology and Skin Diseases (21 papers). Tomomitsu Miyagaki collaborates with scholars based in Japan, United States and Indonesia. Tomomitsu Miyagaki's co-authors include Makoto Sugaya, Shinichi Sato, Hiraku Suga, Yoshihide Asano, Takafumi Kadono, Tomonori Oka, Ayumi Yoshizaki, Hanako Ohmatsu, Thomas F. Tedder and Jonathan C. Poe and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and SHILAP Revista de lepidopterología.

In The Last Decade

Tomomitsu Miyagaki

126 papers receiving 2.7k citations

Hit Papers

Regulatory B cells control T-cell autoimmunity through IL... 2012 2026 2016 2021 2012 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions
    2012 503 citations Ayumi Yoshizaki, Tomomitsu Miyagaki et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomomitsu Miyagaki Japan 29 1.6k 1.1k 624 559 438 131 2.8k
John T. O’Malley United States 23 1.5k 0.9× 880 0.8× 324 0.5× 475 0.8× 247 0.6× 50 2.4k
Earl J. Glusac United States 28 1.4k 0.9× 1.1k 1.0× 564 0.9× 1.2k 2.1× 381 0.9× 81 3.2k
Yohei Iwata Japan 23 1.5k 1.0× 445 0.4× 806 1.3× 295 0.5× 436 1.0× 85 2.9k
Stéphane Barète France 30 777 0.5× 463 0.4× 454 0.7× 418 0.7× 244 0.6× 117 2.3k
Takashi Kakinuma Japan 25 1.1k 0.7× 1.1k 1.0× 334 0.5× 580 1.0× 561 1.3× 34 2.7k
Francesca Cianfarani Italy 20 814 0.5× 407 0.4× 235 0.4× 415 0.7× 680 1.6× 34 2.4k
April Deng United States 24 527 0.3× 487 0.4× 249 0.4× 465 0.8× 444 1.0× 84 1.9k
Steven O’Reilly United Kingdom 33 829 0.5× 436 0.4× 1.2k 1.9× 178 0.3× 898 2.1× 77 2.7k
Mayuka Horikawa United States 20 2.0k 1.3× 168 0.1× 673 1.1× 460 0.8× 310 0.7× 25 3.0k
Paolo Romanelli United States 22 510 0.3× 861 0.8× 421 0.7× 192 0.3× 169 0.4× 112 2.0k

Countries citing papers authored by Tomomitsu Miyagaki

Since Specialization
Citations

This map shows the geographic impact of Tomomitsu Miyagaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomomitsu Miyagaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomomitsu Miyagaki more than expected).

Fields of papers citing papers by Tomomitsu Miyagaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomomitsu Miyagaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomomitsu Miyagaki. The network helps show where Tomomitsu Miyagaki may publish in the future.

Co-authorship network of co-authors of Tomomitsu Miyagaki

This figure shows the co-authorship network connecting the top 25 collaborators of Tomomitsu Miyagaki. A scholar is included among the top collaborators of Tomomitsu Miyagaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomomitsu Miyagaki. Tomomitsu Miyagaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morita, Hiromichi, et al.. (2026). Inducible Costimulator and Its Ligand Promote Proliferation and Migration of Tumor Cells in Cutaneous T-Cell Lymphoma. International Journal of Molecular Sciences. 27(3). 1408–1408.
2.
Miyagaki, Tomomitsu, Hiroaki Kamijo, Naomi Shishido, et al.. (2023). Prognostic factors for primary cutaneous anaplastic large-cell lymphoma: a multicentre retrospective study from Japan. British Journal of Dermatology. 189(5). 612–620. 2 indexed citations
3.
Morimura, Sohshi, Makoto Sugaya, Tomonori Oka, et al.. (2021). Increased Regulatory T Cells and Decreased Myeloid-Derived Suppressor Cells Induced by High CCL17 Levels May Account for Normal Incidence of Cancers among Patients with Atopic Dermatitis. International Journal of Molecular Sciences. 22(4). 2025–2025. 10 indexed citations
4.
Shishido, Naomi, Makoto Sugaya, Hiraku Suga, et al.. (2021). Mycosis fungoides and Sézary syndrome tumor cells express epidermal fatty acid‐binding protein, whose expression decreases with loss of epidermotropism. The Journal of Dermatology. 48(5). 685–689. 6 indexed citations
5.
Kimura, Takayuki, Tomomitsu Miyagaki, Hiraku Suga, et al.. (2021). Lymphatic Dysfunction Exacerbates Cutaneous Tumorigenesis and Psoriasis-Like Skin Inflammation through Accumulation of Inflammatory Cytokines. Journal of Investigative Dermatology. 142(6). 1692–1702.e3. 1 indexed citations
6.
Ohashi, Hiroyuki, Sora Takeuchi, Tomomitsu Miyagaki, & Takafumi Kadono. (2020). Increase of lymphocytes and eosinophils, and decrease of neutrophils at an early stage of anti-PD-1 antibody treatment is a favorable sign for advanced malignant melanoma. Drug Discoveries & Therapeutics. 14(3). 117–121. 12 indexed citations
7.
Ohtsuka, Mikio, Toshihisa Hamada, Tomomitsu Miyagaki, et al.. (2020). Outlines of the Japanese guidelines for the management of primary cutaneous lymphomas 2020. The Journal of Dermatology. 48(2). e49–e71. 12 indexed citations
8.
Sugaya, Makoto, Hideki Fujita, Tomomitsu Miyagaki, et al.. (2020). TLR2 Deficiency Exacerbates Imiquimod-Induced Psoriasis-Like Skin Inflammation through Decrease in Regulatory T Cells and Impaired IL-10 Production. International Journal of Molecular Sciences. 21(22). 8560–8560. 23 indexed citations
9.
Kamijo, Hiroaki, Tomomitsu Miyagaki, Tomonori Oka, et al.. (2020). Primary cutaneous γδ T‐cell lymphoma with unusual immunophenotype: A case report and review of published work. The Journal of Dermatology. 47(3). 300–305. 3 indexed citations
10.
Kamijo, Hiroaki, Tomomitsu Miyagaki, Yoshio Hayashi, et al.. (2019). Increased IL-26 Expression Promotes T Helper Type 17- and T Helper Type 2-Associated Cytokine Production by Keratinocytes in Atopic Dermatitis. Journal of Investigative Dermatology. 140(3). 636–644.e2. 42 indexed citations
11.
Kamijo, Hiroaki, Rina Nakajima, Tomonori Oka, et al.. (2019). YKL-40 Promotes Proliferation of Cutaneous T-Cell Lymphoma Tumor Cells through Extracellular Signal–Regulated Kinase Pathways. Journal of Investigative Dermatology. 140(4). 860–868.e3. 10 indexed citations
12.
Sugaya, Makoto, Rina Nakajima, Tomonori Oka, et al.. (2018). Serum amyloid A levels in the blood of patients with atopic dermatitis and cutaneous T‐cell lymphoma. The Journal of Dermatology. 45(12). 1440–1443. 6 indexed citations
13.
Kamijo, Hiroaki, Tomomitsu Miyagaki, Naomi Shishido, et al.. (2018). Aberrant CD137 ligand expression induced by GATA6 overexpression promotes tumor progression in cutaneous T-cell lymphoma. Blood. 132(18). 1922–1935. 30 indexed citations
14.
Sugaya, Makoto, Rina Nakajima, Tomonori Oka, et al.. (2018). Increased interleukin‐36γ expression in skin and sera of patients with atopic dermatitis and mycosis fungoides/Sézary syndrome. The Journal of Dermatology. 45(4). 468–471. 20 indexed citations
15.
Goto, T., Gojiro Nakagami, Sanae Sasaki, et al.. (2017). Utility of a three-dimensional wound measurement device in pressure ulcers. Volume 4. 129–133. 3 indexed citations
16.
Miyagawa, Takuya, Yoshihide Asano, Ryosuke Saigusa, et al.. (2017). Serum H‐ficolin levels: Clinical association with interstitial lung disease in patients with systemic sclerosis. The Journal of Dermatology. 44(10). 1168–1171. 9 indexed citations
17.
Miyagaki, Tomomitsu, Hiroaki Kamijo, Tomonori Oka, et al.. (2017). Serum vascular endothelial growth factor A levels reflect itch severity in mycosis fungoides and Sézary syndrome. The Journal of Dermatology. 45(1). 95–99. 12 indexed citations
18.
Kamijo, Hiroaki, Makoto Sugaya, N. Takahashi, et al.. (2017). BET bromodomain inhibitor JQ1 decreases CD30 and CCR4 expression and proliferation of cutaneous T-cell lymphoma cell lines. Archives of Dermatological Research. 309(6). 491–497. 10 indexed citations
19.
Miyagaki, Tomomitsu, Rina Nakajima, Tomonori Oka, et al.. (2017). Increased endocan expression in lesional skin and decreased endocan expression in sera in atopic dermatitis. The Journal of Dermatology. 44(12). 1392–1395. 4 indexed citations
20.
Kamata, Masahiro, Yayoi Tada, S. Shibata, et al.. (2013). ICAM-1 Deficiency Exacerbates Sarcoid-Like Granulomatosis Induced by Propionibacterium acnes through Impaired IL-10 Production by Regulatory T Cells. American Journal Of Pathology. 183(6). 1731–1739. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John T. O’Malley Breakdown of academic impact, for papers by Earl J. Glusac Breakdown of academic impact, for papers by Yohei Iwata Breakdown of academic impact, for papers by Stéphane Barète Breakdown of academic impact, for papers by Takashi Kakinuma Breakdown of academic impact, for papers by Francesca Cianfarani Breakdown of academic impact, for papers by April Deng Breakdown of academic impact, for papers by Steven O’Reilly Breakdown of academic impact, for papers by Mayuka Horikawa Breakdown of academic impact, for papers by Paolo Romanelli
Rankless by CCL
2026